IP Library › Granted Patent US 8,454,943
Granted Patent B2
US 8,454,943 · App. 13/440,798 · Granted Jun 4, 2013

Topical skin care formulations comprising plant extracts

Inventors: Tiffany Florence (Dallas, TX); Michelle Hines (Hickory Creek, TX); David Gan (Southlake, TX)
Assignee: Mary Kay Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,454,943
App. No.
13/440,798
Granted
Jun 4, 2013
Kind
B2
Abstract

Disclosed are compositions and corresponding methods of their use that include plant, plant parts, or extracts thereof from Michelia magnifica, Xylosma japonicum, Prunus cerasifera, Nyssa sinensis, Chimonanthus praecox, Sassafras tzumu, Inula helianthus - aquatica, Capparis bodinieri, Passiflora caerulea, Galium aparine, Boehmeria platyphylla, Colquhounia coccinea, Sageretia rugosa, Jasminum stephanense, Antirrhinum majus, Daphniphyllum oldhamii, Cuscuta chinensis, Salix variegate, Osmanthus parvifolius, Euphorbia trigona, Calliandra haematocephala, Excoecaria acerifolia, Dianthus chinensis, Myriophyllum spicatum, Nymphoides peltatum, Prunus salicina, Solanum coagulans, Elaeis guineensis, Rhododendron moulmainense, Spatholobus suberectus, Artabotrys hexapetalus, Hibiscus syriacus, Lonicera calcarata, Hydnocarpus hainanensis, Ilex fragilis, Antidesma venosum, Acacia pennata ssp. Kerrii, Althaea rosea, Millettia velutina, Themeda japonica, Dalbergia hancei, Ipomoea batatas, Photinia glomerate, Hippophae rhamnoides, Azadirachta indica, Karelinia caspica, Bauhinia touranensis, Eriobotrya japonicas, Anaphalis contorta , and/or Cratoxylum prunifolium , or any combination thereof.

Claims (19)

1. A topical skin composition comprising:

(a) a first MMP-1 inhibitor, wherein said first inhibitor is an aqueous extract from Boehmeria platyphylla;

(b) a second MMP-1 inhibitor, wherein said second inhibitor is an aqueous extract from Cratoxylum prunifolium ; and

(c) a third MMP-1 inhibitor, wherein said third inhibitor is an aqueous extract from Excoecaria acerifolia.

2. The topical skin composition of claim 1 , wherein the composition is an emulsion, cream, lotion, or solution.

3. The topical skin composition of claim 2 , wherein the composition includes from about 0.001% to about 5% by weight of said aqueous extract from Boehmeria platyphylla , from about 0.001% to about 5% by weight of said aqueous extract from Cratoxylum prunifolium , and from about 0.001% to about 5% by weight of said aqueous extract from Excoecaria acerifolia.

4. The topical skin composition of claim 3 , wherein the composition comprises a moisturization agent, an antioxidant, a structuring or thickening agent, and an emulsifier.

5. The topical skin composition of claim 4 , wherein the composition further includes a silicone containing compound.

6. The topical skin composition of claim 5 , wherein the composition further includes a sunscreen agent.

7. The topical skin composition of claim 1 , wherein each of said aqueous extracts are obtained from the whole plant of Boehmeria platyphylla, Cratoxylum prunifolium , and Excoecaria acerifolia , respectively.

8. The topical skin composition of claim 1 , wherein the composition is a cleanser product, a toner product, a moisturizer product, or a mask product.

9. The topical skin composition of claim 1 , wherein said first MMP-1 inhibitor is also an antioxidant, a TNF-α inhibitor, and a lipoxygenase inhibitor, wherein said second MMP-1 inhibitor is also an antioxidant, and wherein said third MMP-1 inhibitor is also an antioxidant and a lipoxygenase inhibitor.

10. A method of treating skin comprising topically applying the composition of claim 1 to skin in need thereof, wherein topical application of said composition treats said skin.

11. The method of claim 10 , wherein the composition inhibits MMP-1 activity and lipoxygenase activity in said skin.

12. The method of claim 11 , wherein the composition is applied to a fine line or wrinkle.

13. The method of claim 10 , wherein the composition inhibits TNF-α activity in said skin.

14. The method of claim 13 , wherein the composition is applied to erythemic or inflamed skin.

15. The method of claim 10 , wherein the composition reduces oxidative damage in skin cells.

16. The method of claim 10 , wherein each of said aqueous extracts are obtained from the whole plant of Boehmeria platyphylla, Cratoxylum prunifolium , and Excoecaria acerifolia , respectively.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2012
From: FLORENCE, TIFFANY; HINES, MICHELLE; GAN, DAVID
To: MARY KAY, INC.
Reel/Frame 028558/0198 →
Continuity (2)
Provisional Application 61472461 · Apr 6, 2011
Related Publication 20120276025A1 · Nov 1, 2012